Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants

被引:26
作者
Al-Lamki, RS
Wang, J
Thiru, S
Pritchard, NR
Bradley, JA
Pober, JS
Bradley, JR
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
[2] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England
[3] Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 2QQ, England
[4] Yale Univ, Sch Med, Boyer Ctr Mol Med, New Haven, CT USA
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
D O I
10.1016/S0002-9440(10)63670-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We have previously reported the pattern of cellular expression of tumor necrosis factor receptors (TNFR) in human kidney and their altered expression in transplant rejection. We have extended our studies to examine the expression of Silencer of Death Domains (SODD), a protein that binds to the cytoplasmic portion of TNFR1 to inhibit signaling in the absence of ligand. In normal human kidney SODD is expressed in glomerular endothelial cells where it colocalizes; with TNFR1. During acute rejection both SODD and TNFR1 are lost from glomeruli, but we found strong expression of SODD on the luminal surface of tubular epithelial cells. This occurs in the absence of detectable TNFR1 expression, suggesting that SODD could interact with other proteins at these sites. Several other members of the TNF superfamily, including Fas and death receptors (DR)-3, -4, and -5, also contain intracellular death domains, but SODD only interacts with the death domain of DR3. We therefore studied the expression of DR3 in human kidney, and report that this death receptor is up-regulated in renal tubular epithelial cells and endothelial cells of some interlobular arteries, in parallel with SODD, during acute transplant rejection. in less severe rejection episodes, DR3 and SODD were more focally induced, generally at sites of mononuclear cell infiltrates. In ischemic allografts, eg, with acute tubular necrosis but no cellular rejection, DR3 was induced on tubular epithelial cells and on glomerular endothelial. cells. These data confirm that TNF receptor family members are expressed in a regulated manner during renal transplant rejection, and identify DR3 as a potential inducible mediator of tubular inflammation and injury.
引用
收藏
页码:401 / 411
页数:11
相关论文
共 20 条
[1]   Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants [J].
Al-Lamki, RS ;
Wang, J ;
Skepper, JN ;
Thiru, S ;
Pober, JS ;
Bradley, JR .
LABORATORY INVESTIGATION, 2001, 81 (11) :1503-1515
[2]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[3]   The three-dimensional solution structure and dynamic properties of the human FADD death domain [J].
Berglund, H ;
Olerenshaw, D ;
Sankar, A ;
Federwisch, M ;
McDonald, NQ ;
Driscoll, PC .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 302 (01) :171-188
[4]   TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95) [J].
Bodmer, JL ;
Burns, K ;
Schneider, P ;
Hofmann, K ;
Steiner, V ;
Thome, M ;
Bornand, T ;
Hahne, M ;
Schroter, M ;
Becker, K ;
Wilson, A ;
French, LE ;
Browning, JL ;
MacDonald, HR ;
Tschopp, J .
IMMUNITY, 1997, 6 (01) :79-88
[5]  
BRADLEY JR, 1995, AM J PATHOL, V146, P27
[6]   TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis [J].
Chicheportiche, Y ;
Bourdon, PR ;
Xu, HD ;
Hsu, YM ;
Scott, H ;
Hession, C ;
Garcia, I ;
Browning, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :32401-32410
[7]   Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95 [J].
Chinnaiyan, AM ;
ORourke, K ;
Yu, GL ;
Lyons, RH ;
Garg, M ;
Duan, DR ;
Xing, L ;
Gentz, R ;
Ni, J ;
Dixit, VM .
SCIENCE, 1996, 274 (5289) :990-992
[8]   The kiss of death: promises and failures of death receptors and ligands in cancer therapy [J].
Daniel, PT ;
Wieder, T ;
Sturm, I ;
Schulze-Osthoff, K .
LEUKEMIA, 2001, 15 (07) :1022-1032
[9]   Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system [J].
Eggert, A ;
Grotzer, MA ;
Zuzak, TJ ;
Ikegaki, N ;
Zhao, H ;
Brodeur, GM .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (01) :92-98
[10]   TR3 death receptor expression in the normal and ischaemic brain [J].
Harrison, DC ;
Roberts, J ;
Campbell, CA ;
Crook, B ;
Davis, R ;
Deen, K ;
Meakin, J ;
Michalovich, D ;
Price, J ;
Stammers, M ;
Maycox, PR .
NEUROSCIENCE, 2000, 96 (01) :147-160